Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phillips Edison & Co Inc - Ordinary Shares - New | Jeffrey S. Edison | Director, Chairman and CEO | Other type of transaction at price $ 0.00 per share. | 12 Nov 2025 | 1,999,800 | 2,020,000 | - | - | OP Units | |
| Phillips Edison & Co Inc - Ordinary Shares - New | Jeffrey S. Edison | Director, Chairman and CEO | Other type of transaction at price $ 0.00 per share. | 12 Nov 2025 | 1,999,800 | 2,020,000 | - | - | OP Units | |
| ETHZilla Corp | McAndrew Rudisill | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 1,365,000 | 1,365,000 | - | 0 | Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 1,283,500 | 215,222 | - | 0 | Class A Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 12 Nov 2025 | 1,250,000 | 5,343,347 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 12 Nov 2025 | 1,250,000 | 1,498,722 | - | - | Class A Common Stock | ||
| ETHZilla Corp | Jason G. New | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 952,500 | 952,500 | - | 0 | Common Stock | |
| ETHZilla Corp | Ryan L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 887,500 | 904,218 | - | 0 | Common Stock | |
| Moleculin Biotech Inc | Walter V. Klemp | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 830,000 | 3,210,731 | - | - | Stock option (right to buy) | |
| ACM Research Inc (Class A) | Haiping Dun | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 755,090 | 0 (0%) | 4% | 0 | Class A Common Stock | |
| Moleculin Biotech Inc | Walter V. Klemp | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 750,000 | 3,960,731 | - | - | Performance Based Restricted Stock Units | |
| Finance of America Companies Inc | Graham A. Fleming | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 700,000 | 700,000 | - | - | Class B Units of Finance of America Equity Capital LLC | |
| Finance of America Companies Inc | Jeremy Prahm | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 700,000 | 700,000 | - | - | Class B Units of Finance of America Equity Capital LLC | |
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.87 per share. | 12 Nov 2025 | 700,000 | 1,300,000 (2%) | 1% | 2.9 | 2,009,000 | Class A Common Stock |
| ETHZilla Corp | Andrew Suckling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 649,748 | 649,748 | - | 0 | Common Stock | |
| ETHZilla Corp | Crystal Heter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 649,748 | 649,748 | - | 0 | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 600,000 | 1,617,695 | - | - | Stock option (right to buy) | |
| SoFi Tech Inc | Christopher Lapointe | CFO and PAO | 12 Nov 2025 | 500,000 | 500,000 | - | - | Prepaid Forward Contract | ||
| Thumzup Media Corp | Robert Haag | Former Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2025 | 500,000 | 5,125 | - | - | Common Stock | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 12 Nov 2025 | 447,803 | 0 | - | 2.4 | 1,061,293 | Class A Common Stock |
| ETHZilla Corp | McAndrew Rudisill | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 410,865 | 682,500 | - | 0 | Common Stock | |
| Finance of America Companies Inc | Kristen N. Sieffert | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 400,000 | 400,000 | - | - | Class B Units of Finance of America Equity Capital LLC | |
| Moleculin Biotech Inc | Jonathan P. Foster | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 400,000 | 2,017,695 | - | - | Performance Based Restricted Stock Units | |
| ETHZilla Corp | McAndrew Rudisill | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 370,000 | 415,283 | - | 0 | Common Stock | |
| KKR | Henry R. Kravis | Director, Co-Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 350,000 | 5,460,000 (0%) | 0% | 0 | Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 12 Nov 2025 | 281,250 | 4,995,021 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 12 Nov 2025 | 281,250 | 281,250 | - | - | Class A Common Stock | ||
| ETHZilla Corp | McAndrew Rudisill | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Nov 2025 | 271,635 | 1,093,365 | - | 0 | Common Stock | |
| ETHZilla Corp | Ryan L. Smith | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 267,137 | 267,137 | - | 0 | Common Stock | |
| ETHZilla Corp | Ryan L. Smith | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 267,137 | 460,468 | - | 0 | Common Stock | |
| ETHZilla Corp | Jason G. New | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Nov 2025 | 257,794 | 711,424 | - | 0 | Common Stock | |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | Sale of securities on an exchange or to another person at price $ 218.27 per share. | 12 Nov 2025 | 254,553 | 709,820 (0%) | 0% | 218.3 | 55,561,283 | Common Stock, par value $.01 |
| Alphatec Holdings Inc | David R. Pelizzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.80 per share. | 12 Nov 2025 | 250,000 | 11,145,045 (18%) | 0% | 20.8 | 5,200,000 | Common Stock |
| ARS Pharma Inc | Pratik Shah | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 250,000 | 4,574,554 | - | 0 | Common Stock | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Sale of securities on an exchange or to another person at price $ 2.72 per share. | 12 Nov 2025 | 227,431 | 447,803 | - | 2.7 | 619,363 | Class A Common Stock |
| ETHZilla Corp | Jason G. New | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 218,456 | 218,456 | - | 0 | Common Stock | |
| ETHZilla Corp | Jason G. New | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 218,456 | 492,250 | - | 0 | Common Stock | |
| EZCorp Inc (Class A) | Lachlan P. Given | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 210,084 | 1,114,560 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Donald H. Picker | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 200,000 | 295,508 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Donald H. Picker | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 200,000 | 495,508 | - | - | Performance Based Restricted Stock Units | |
| ETHZilla Corp | Crystal Heter | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 182,742 | 182,742 | - | 0 | Common Stock | |
| ETHZilla Corp | Crystal Heter | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 182,742 | 182,742 | - | 0 | Common Stock | |
| Sweetgreen Inc (Class A) | Jonathan Neman | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 5.56 per share. | 12 Nov 2025 | 179,800 | 179,800 | - | 5.6 | 999,688 | Class A Common Stock |
| ETHZilla Corp | Ryan L. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Nov 2025 | 176,613 | 727,605 | - | 0 | Common Stock | |
| H&R Block Inc | Jeffrey J. Jones | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 46.46 per share. | 12 Nov 2025 | 176,449 | 906,312 (0%) | 0% | 46.5 | 8,198,173 | Common Stock |
| ETHZilla Corp | Andrew Suckling | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Nov 2025 | 175,854 | 473,894 | - | 0 | Common Stock | |
| Halliburton | Mark J. Richard | President - Western Hemisphere | Sale of securities on an exchange or to another person at price $ 27.77 per share. | 12 Nov 2025 | 160,000 | 452,373 (0%) | 0% | 27.8 | 4,443,200 | Common Stock |
| Finance of America Companies Inc | Lauren Richmond | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 150,000 | 150,000 | - | - | Class B Units of Finance of America Equity Capital LLC | |
| Moleculin Biotech Inc | Michael D. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 150,000 | 165,336 | - | - | Stock Options (right to buy) | |
| Moleculin Biotech Inc | Elizabeth A. Cermak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 150,000 | 164,668 | - | - | Stock Options (right to buy) | |
| Moleculin Biotech Inc | John M. Climaco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 150,000 | 165,169 | - | - | Stock Options (right to buy) | |
| Moleculin Biotech Inc | Robert E. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 150,000 | 165,336 | - | - | Stock Options (right to buy) | |
| Moleculin Biotech Inc | Joy Yan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 150,000 | 164,001 | - | - | Stock Options (right to buy) | |
| ETHZilla Corp | Andrew Suckling | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 149,020 | 149,020 | - | 0 | Common Stock | |
| ETHZilla Corp | Andrew Suckling | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 149,020 | 149,020 | - | 0 | Common Stock | |
| H&R Block Inc | Jeffrey J. Jones | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.73 per share. | 12 Nov 2025 | 145,087 | 1,082,761 (0%) | 0% | 29.7 | 4,313,437 | Common Stock |
| H&R Block Inc | Jeffrey J. Jones | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 145,087 | 128,818 | - | - | Stock Option (Right to Buy) | |
| ETHZilla Corp | Crystal Heter | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Nov 2025 | 142,132 | 507,616 | - | 0 | Common Stock | |
| Intuitive Machines Inc (Class A) | Michael Blitzer | Director | Purchase of securities on an exchange or from another person at price $ 9.27 per share. | 12 Nov 2025 | 141,080 | 1,831,248 | - | 9.3 | 1,307,205 | Class A Common Stock |
| ARS Pharma Inc | Justin Chakma | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 8.86 per share. | 12 Nov 2025 | 136,380 | 0 | - | 8.9 | 1,208,790 | Common Stock |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | Sale of securities on an exchange or to another person at price $ 219.43 per share. | 12 Nov 2025 | 133,233 | 576,587 (0%) | 0% | 219.4 | 29,235,317 | Common Stock, par value $.01 |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 11.92 per share. | 12 Nov 2025 | 131,856 | 146,403 (0%) | 0% | 11.9 | 1,571,724 | Class A Common Stock |
| Playtika Holding Corp | Uri Rubin | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 125,000 | 657,066 | - | 0 | Common Stock | |
| Playtika Holding Corp | Erez Hershkovitz | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 123,457 | 123,457 | - | 0 | Common Stock | |
| Kiniksa Pharma Ltd (Class A) | Sanj K. Patel | Director, CHAIRMAN & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 111,794 | 111,794 (0%) | 0% | 0 | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | Sanj K. Patel | Director, CHAIRMAN & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 111,794 | 0 (0%) | 0% | 0 | Class A Ordinary Share | |
| ETHZilla Corp | John Tazewell Saunders | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 109,312 | 109,312 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. | 12 Nov 2025 | 100,000 | 123,400 | - | 0.2 | 18,000 | Common Stock |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.12 per share. | 12 Nov 2025 | 100,000 | 23,400 | - | 21.1 | 2,112,450 | Common Stock |
| Edgewise Therapeutics Inc | Alan Russell | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 100,000 | 1,147,365 | - | - | Stock Option (Right to Buy) | |
| Exelixis Inc | Stelios Papadopoulos | Director | Sale of securities on an exchange or to another person at price $ 43.55 per share. | 12 Nov 2025 | 100,000 | 1,189,228 (0%) | 0% | 43.6 | 4,355,000 | Common Stock |
| Intuitive Machines Inc (Class A) | Michael Blitzer | Director | Purchase of securities on an exchange or from another person at price $ 8.83 per share. | 12 Nov 2025 | 100,000 | 1,931,248 | - | 8.8 | 883,230 | Class A Common Stock |
| BRC Inc (Class A) | Steven M. Taslitz | Director | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 12 Nov 2025 | 100,000 | 451,184 | - | 1.3 | 128,450 | Class A Common Stock |
| ARS Pharma Inc | Pratik Shah | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 100,000 | 4,474,554 | - | 0 | Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 95,525 | 0 | - | - | Stock Option (Right to Buy) | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share. | 12 Nov 2025 | 95,525 | 278,259 (0%) | 0% | 2.8 | 262,694 | Class A Common Stock |
| Karman Holdings Inc | Brian Raduenz | Director | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 12 Nov 2025 | 90,000 | 254,105 | - | 68.0 | 6,120,135 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 85.82 per share. | 12 Nov 2025 | 85,746 | 195,504 | - | 85.8 | 7,358,799 | Class A Common Stock |
| EZCorp Inc (Class A) | John Blair Powell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 84,034 | 470,259 | - | - | Restricted Stock Units | |
| iPower Inc | Chenlong Tan | Director, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 81,136 | 207,866 | - | 0 | Common Stock | |
| Advanced Drainage Systems Inc | D. Scott Barbour | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.75 per share. | 12 Nov 2025 | 80,030 | 122,897 (0%) | 0% | 25.8 | 2,060,773 | Common Stock |
| Advanced Drainage Systems Inc | D. Scott Barbour | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 80,030 | 0 | - | - | Option to Purchase Common Stock | |
| Research Soln Inc | Merrill A. McPeak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.70 per share. | 12 Nov 2025 | 75,000 | 484,608 | - | 0.7 | 52,500 | Common Stock |
| Research Soln Inc | Merrill A. McPeak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 75,000 | 0 | - | - | Option to purchase common stock | |
| EZCorp Inc (Class A) | Timothy K. Jugmans | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 73,529 | 319,486 | - | - | Restricted Stock Units | |
| Advanced Drainage Systems Inc | D. Scott Barbour | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 148.96 per share. | 12 Nov 2025 | 73,462 | 44,897 (0%) | 0% | 149.0 | 10,942,877 | Common Stock |
| GrowGeneration Corp | Darren Lampert | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.74 per share. | 12 Nov 2025 | 70,280 | 1,708,242 (4%) | 0% | 1.7 | 122,287 | Common Stock |
| Emerson Electric | Ram R. Krishnan | Executive Vice Pres & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Emerson Electric | Ram R. Krishnan | Executive Vice Pres & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Emerson Electric | Ram R. Krishnan | Executive Vice Pres & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Emerson Electric | Ram R. Krishnan | Executive Vice Pres & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Emerson Electric | Ram R. Krishnan | Executive Vice Pres & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Organon & Co. | Carrie S. Cox | Director, Executive Chair | Purchase of securities on an exchange or from another person at price $ 7.67 per share. | 12 Nov 2025 | 65,400 | 77,869 | - | 7.7 | 501,755 | Common Stock |
| Kiniksa Pharma Ltd (Class A) | Sanj K. Patel | Director, CHAIRMAN & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 60,000 | 51,794 (0%) | 0% | 0 | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | Sanj K. Patel | Director, CHAIRMAN & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 60,000 | 60,000 (0%) | 0% | 0 | Class A Ordinary Share | |
| Unum Grp | Richard P. Mckenney | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 60,000 | 920,637 (0%) | 0% | 0 | Common Stock | |
| Research Soln Inc | John J. Regazzi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 60,000 | 60,000 | - | - | Option to purchase common stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 87.81 per share. | 12 Nov 2025 | 59,113 | 78,869 | - | 87.8 | 5,190,470 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 86.92 per share. | 12 Nov 2025 | 57,522 | 137,982 | - | 86.9 | 4,999,657 | Class A Common Stock |
| McCormick & Company | Brendan M. Foley | Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 57,144 | 0 | - | - | Options - Right to Buy | |
| McCormick & Company | Brendan M. Foley | Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 65.56 per share. | 12 Nov 2025 | 57,144 | 108,652 (1%) | 0% | 65.6 | 3,746,361 | Common Stock - Voting |
| McCormick & Company | Brendan M. Foley | Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.96 per share. | 12 Nov 2025 | 57,144 | 165,796 (1%) | 0% | 50.0 | 2,854,914 | Common Stock - Voting |
| GrowGeneration Corp | Darren Lampert | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.61 per share. | 12 Nov 2025 | 56,540 | 1,651,702 (4%) | 0% | 1.6 | 91,029 | Common Stock |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 12 Nov 2025 | 54,333 | 0 | - | 2.4 | 128,769 | Class A Common Stock |
| Charles Schwab | Charles R. Schwab | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 52,500 | 56,119,454 (4%) | 0% | 0 | Common Stock | |
| Surrozen Inc | Andrew Pedrum Maleki | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Finance of America Companies Inc | Matthew A. Engel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 50,000 | 50,000 | - | - | Class B Units of Finance of America Equity Capital LLC | |
| Research Soln Inc | Barbara J. Cooperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 50,000 | 50,000 | - | - | Option to purchase common stock | |
| Research Soln Inc | Jeremy Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 50,000 | 50,000 | - | - | Option to purchase common stock | |
| Research Soln Inc | Merrill A. McPeak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 50,000 | 50,000 | - | - | Option to purchase common stock | |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 12 Nov 2025 | 48,300 | 569,356 (0%) | 0% | 16.6 | 802,263 | Common Stock |
| HBT Fin Inc | Fred L. Drake | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 45,815 | 7,705 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Granite Point Mortgage Trust Inc | Stephen G. Kasnet | Director | Sale of securities on an exchange or to another person at price $ 2.69 per share. | 12 Nov 2025 | 45,000 | 138,566 (0%) | 0% | 2.7 | 121,050 | Common Stock |
| Cencora | Robert P. Mauch | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 42,944 | 85,756 (0%) | 0% | 0 | Common Stock | |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.42 per share. | 12 Nov 2025 | 40,000 | 161,503 | - | 9.4 | 376,800 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 12 Nov 2025 | 40,000 | 121,503 | - | 26 | 1,040,000 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Tia Bush | Chief Technology & Quality Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 40,000 | 400,338 | - | - | Share Option (right to buy) | |
| Catalyst Pharma Inc | Brian Elsbernd | Chief Compliance/Legal Officer | Sale of securities on an exchange or to another person at price $ 22.70 per share. | 12 Nov 2025 | 40,000 | 231,039 (0%) | 0% | 22.7 | 908,000 | Common Stock, par value $0.001 per share |
| Xometry Inc (Class A) | Randolph Altschuler | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 40,000 | 591,270 | - | 0 | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 36,331 | 0 | - | - | Stock Option (Right to Buy) | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share. | 12 Nov 2025 | 36,331 | 182,734 (0%) | 0% | 2.7 | 99,910 | Class A Common Stock |
| Gilead Sciences | Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 35,965 | 12,655 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Deborah H. Telman | EVP, Corporate Affairs & GC | Sale of securities on an exchange or to another person at price $ 122.30 per share. | 12 Nov 2025 | 35,965 | 43,676 (0%) | 0% | 122.3 | 4,398,591 | Common Stock |
| Gilead Sciences | Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.75 per share. | 12 Nov 2025 | 35,965 | 79,641 (0%) | 0% | 60.8 | 2,184,874 | Common Stock |
| Collegium pharma Inc | John A. Fallon | Director | Sale of securities on an exchange or to another person at price $ 47.21 per share. | 12 Nov 2025 | 34,853 | 64,634 (0%) | 0% | 47.2 | 1,645,536 | Common Stock |
| Diamondback | Charles A. Meloy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 34,000 | 1,044,864 (0%) | 0% | 0 | Common Stock | |
| Bellring Brands Inc | Darcy Horn Davenport | PRES. AND CEO | Grant, award, or other acquisition of securities at price $ 27.61 per share. | 12 Nov 2025 | 33,683 | 236,381 (0%) | 0% | 27.6 | 929,988 | Common Stock |
| Ventas | Robert F. Probst | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 33,591 | 0 | - | - | Stock Option (Right to Buy) | |
| Ventas | Robert F. Probst | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.71 per share. | 12 Nov 2025 | 33,591 | 201,955 (0%) | 0% | 73.7 | 2,475,993 | Common Stock |
| Ventas | Robert F. Probst | EVP and CFO | Sale of securities on an exchange or to another person at price $ 76.77 per share. | 12 Nov 2025 | 33,591 | 168,364 (0%) | 0% | 76.8 | 2,578,845 | Common Stock |
| Bakkt Holdings Inc (Class A) | Akshay Naheta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 33,557 | 1,308,725 | - | - | Stock Option (right to buy) | |
| Bakkt Holdings Inc (Class A) | Akshay Naheta | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 12 Nov 2025 | 33,557 | 294,716 | - | 10 | 335,570 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 88.76 per share. | 12 Nov 2025 | 31,357 | 47,512 | - | 88.8 | 2,783,229 | Class A Common Stock |
| LoanDepot Inc (Class A) | Dawn G. Lepore | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 12 Nov 2025 | 30,624 | 168,542 (0%) | 0% | 2.9 | 88,503 | Class A Common Stock |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 30,200 | 160,011 | - | - | Restricted Stock Units | |
| Cencora | James F. Cleary | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 30,062 | 147,790 (0%) | 0% | 0 | Common Stock | |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.42 per share. | 12 Nov 2025 | 30,000 | 596,805 | - | 30.4 | 912,597 | Class A Ordinary Shares, par value $0.05 per share |
| Insmed Inc | S. Nicole Schaeffer | Chief People Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 30,000 | 15,760 | - | - | Stock Option (right to buy) | |
| Insmed Inc | S. Nicole Schaeffer | Chief People Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. | 12 Nov 2025 | 30,000 | 66,461 (0%) | 0% | 26.5 | 793,800 | Common Stock |
| ARS Pharma Inc | Justin Chakma | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 12 Nov 2025 | 30,000 | 136,380 | - | 8.9 | 267,357 | Common Stock |
| ARS Pharma Inc | Justin Chakma | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 12 Nov 2025 | 30,000 | 166,380 | - | 0.8 | 25,200 | Common Stock |
| ARS Pharma Inc | Justin Chakma | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 30,000 | 89,047 | - | - | Stock Option (Right to Buy) | |
| ProKidney Corp Ordinary | Brian J.G. Pereira | Director | Sale of securities on an exchange or to another person at price $ 2.72 per share. | 12 Nov 2025 | 27,595 | 54,333 | - | 2.7 | 75,152 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 89.73 per share. | 12 Nov 2025 | 26,429 | 21,083 | - | 89.7 | 2,371,493 | Class A Common Stock |
| EZCorp Inc (Class A) | Lisa VanRoekel | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 26,261 | 156,517 | - | - | Restricted Stock Units | |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | Sale of securities on an exchange or to another person at price $ 217.64 per share. | 12 Nov 2025 | 25,855 | 964,373 (0%) | 0% | 217.6 | 5,627,082 | Common Stock, par value $.01 |
| BridgeBio Pharma Inc | Hannah A. Valantine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 25,484 | 25,484 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Hannah A. Valantine | Director | Sale of securities on an exchange or to another person at price $ 66.07 per share. | 12 Nov 2025 | 25,484 | 7,465 (0%) | 0% | 66.1 | 1,683,728 | Common Stock |
| BridgeBio Pharma Inc | Hannah A. Valantine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.45 per share. | 12 Nov 2025 | 25,484 | 32,949 (0%) | 0% | 48.5 | 1,234,700 | Common Stock |
| ASP Isotopes Inc | Todd Michael Wider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 25,469 | 735,699 | - | - | Common Stock | |
| SEI Investments Co. | Michael N. Peterson | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 25,000 | 0 | - | - | Option to Purchase Common Stock | |
| SEI Investments Co. | Michael N. Peterson | EXECUTIVE VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 84.21 per share. | 12 Nov 2025 | 25,000 | 13,500 (0%) | 0% | 84.2 | 2,105,250 | Common Stock |
| SEI Investments Co. | Michael N. Peterson | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.34 per share. | 12 Nov 2025 | 25,000 | 38,500 (0%) | 0% | 54.3 | 1,358,500 | Common Stock |
| Globus Medical Inc (Class A) | David D. Davidar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.52 per share. | 12 Nov 2025 | 25,000 | 541,275 (0%) | 0% | 25.5 | 638,000 | Class A Common Stock |
| Globus Medical Inc (Class A) | David D. Davidar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 25,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David D. Davidar | Director | Sale of securities on an exchange or to another person at price $ 86.00 per share. | 12 Nov 2025 | 25,000 | 516,275 (0%) | 0% | 86.0 | 2,150,005 | Class A Common Stock |
| Repligen Corp | Tony J. Hunt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.87 per share. | 12 Nov 2025 | 25,000 | 125,743 (0%) | 0% | 33.9 | 846,750 | Common Stock |
| Repligen Corp | Tony J. Hunt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 25,000 | 157,344 | - | - | Stock Option (Right to Buy) | |
| WisdomTree Inc | R. Jarrett | President and COO | Sale of securities on an exchange or to another person at price $ 11.77 per share. | 12 Nov 2025 | 25,000 | 1,011,138 (0%) | 0% | 11.8 | 294,250 | Common Stock |
| Peloton Interactive Inc | Karen Boone | Director | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 12 Nov 2025 | 25,000 | 237,174 (0%) | 0% | 7.4 | 185,858 | Class A Common Stock |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.28 per share. | 12 Nov 2025 | 24,554 | 662,251 | - | 31.3 | 768,049 | Class A Ordinary Shares, par value $0.05 per share |
| Cannae Holdings Inc | Douglas K. Ammerman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 23,453 | 62,356 (0%) | 0% | 0 | Common Stock | |
| ETHZilla Corp | John Tazewell Saunders | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Nov 2025 | 23,447 | 85,865 | - | 0 | Common Stock | |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | Sale of securities on an exchange or to another person at price $ 220.15 per share. | 12 Nov 2025 | 23,359 | 553,228 (0%) | 0% | 220.2 | 5,142,484 | Common Stock, par value $.01 |
| Post Holdings Inc | Robert V. Vitale | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 23,227 | 937,908 (1%) | 0% | 0 | Common Stock | |
| Post Holdings Inc | Robert V. Vitale | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 23,227 | 0 | - | - | Restricted Stock Units | |
| Ecolab | Christophe Beck | Director, CHAIRMAN & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.12 per share. | 12 Nov 2025 | 23,071 | 94,358 (0%) | 0% | 119.1 | 2,748,218 | Common Stock |
| Ecolab | Christophe Beck | Director, CHAIRMAN & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 23,071 | 23,071 | - | - | Employee Stock Option (Right to Buy) | |
| Gates Industrial Corp PLC | L. Brooks Mallard | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.77 per share. | 12 Nov 2025 | 22,188 | 177,627 (0%) | 0% | 22.8 | 505,221 | Ordinary Shares |
| Plexus Corp | Todd P. Kelsey | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 21,583 | 80,297 (0%) | 0% | - | Common Stock, $.01 par value | |
| Plexus Corp | Todd P. Kelsey | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 21,583 | 13,150 | - | - | Performance Stock Units | |
| Zurn Elkay Water Soln Corp | Mark W. Peterson | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 48.48 per share. | 12 Nov 2025 | 21,570 | 318,561 (0%) | 0% | 48.5 | 1,045,714 | Common Stock |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.85 per share. | 12 Nov 2025 | 21,432 | 635,373 | - | 31.8 | 682,609 | Class A Ordinary Shares, par value $0.05 per share |
| Staar Surgical Co. | Wei Jiang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 20,967 | 45,477 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Wei Jiang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 20,967 | 20,967 | - | - | Restricted Stock Units | |
| Procore Tech Inc | O Kevin J Connor | Director | Sale of securities on an exchange or to another person at price $ 77.66 per share. | 12 Nov 2025 | 20,906 | 1,087,039 | - | 77.7 | 1,623,560 | Common Stock |
| Cencora | Elizabeth S. Campbell | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 20,613 | 35,920 (0%) | 0% | 0 | Common Stock | |
| Alarm.com Holdings Inc | Daniel Kerzner | See Remarks | Sale of securities on an exchange or to another person at price $ 50.29 per share. | 12 Nov 2025 | 20,004 | 52,000 (0%) | 0% | 50.3 | 1,006,001 | Common Stock |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 20,000 | 79,100 | - | - | Employee Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.46 per share. | 12 Nov 2025 | 20,000 | 32,726 (0%) | 0% | 40.5 | 809,200 | Class A Common Stock |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 20,000 | 157,708 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 65.07 per share. | 12 Nov 2025 | 20,000 | 247,863 (0%) | 0% | 65.1 | 1,301,410 | Common Stock |
| Revolution Medicines Inc | Mark A. Goldsmith | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 12 Nov 2025 | 20,000 | 267,863 (0%) | 0% | 4.1 | 81,800 | Common Stock |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.94 per share. | 12 Nov 2025 | 19,900 | 31,086 (0%) | 0% | 40.9 | 814,706 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 19,900 | 0 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.93 per share. | 12 Nov 2025 | 19,900 | 50,986 (0%) | 0% | 30.9 | 615,507 | Class A Ordinary Share |
| Collegium pharma Inc | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 19,853 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.33 per share. | 12 Nov 2025 | 19,853 | 99,487 (0%) | 0% | 9.3 | 185,228 | Common Stock |
| Insmed Inc | S. Nicole Schaeffer | Chief People Strategy Officer | Sale of securities on an exchange or to another person at price $ 194.44 per share. | 12 Nov 2025 | 19,183 | 36,625 (0%) | 0% | 194.4 | 3,729,943 | Common Stock |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.34 per share. | 12 Nov 2025 | 18,865 | 110,314 (0%) | 0% | 101.3 | 1,911,779 | Ordinary Shares |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 18,865 | 45,815 | - | - | NQ Options | |
| Cipher Mining Inc | Wesley Williams | Director | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 12 Nov 2025 | 18,769 | 208,012 | - | 17.5 | 328,645 | Common Stock |
| Cencora | Robert P. Mauch | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.53 per share. | 12 Nov 2025 | 18,677 | 67,079 (0%) | 0% | 312.5 | 5,837,123 | Common Stock |
| EZCorp Inc (Class A) | James W. Fugitt | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 18,382 | 18,382 | - | - | Restricted Stock Units | |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.31 per share. | 12 Nov 2025 | 18,080 | 91,449 (0%) | 0% | 64.3 | 1,162,725 | Ordinary Shares |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 18,080 | 33,147 | - | - | NQ Options | |
| Bridgewater Bancshares Inc | Jerry J. Baack | Director, CEO | Sale of securities on an exchange or to another person at price $ 17.07 per share. | 12 Nov 2025 | 18,007 | 1,171,354 (4%) | 0% | 17.1 | 307,387 | Common Stock |
| Aon (Class A) | Gloria Santona | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 17,736 | 21,871 (0%) | 0% | 0 | Class A Ordinary Stock | |
| Aon (Class A) | Gloria Santona | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 17,736 | 17,736 (0%) | 0% | 0 | Class A Ordinary Stock | |
| Bolt Projects Holdings Inc (Class A) | Randy Befumo | INTERIM CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 17,672 | 72,976 | - | 0 | Common Stock | |
| Expedia Group | Dara Khosrowshahi | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 17,500 | 133,258 (0%) | 0% | 0 | Common Stock | |
| COPT Defense Properties | Anthony Mifsud | EVP AND CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 17,400 | 223,008 | - | - | Common Units-CDPLP | |
| Ecolab | Christophe Beck | Director, CHAIRMAN & CEO | Sale of securities on an exchange or to another person at price $ 261.17 per share. | 12 Nov 2025 | 17,252 | 77,106 (0%) | 0% | 261.2 | 4,505,636 | Common Stock |
| Gilead Sciences | Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.12 per share. | 12 Nov 2025 | 17,181 | 60,857 (0%) | 0% | 75.1 | 1,290,637 | Common Stock |
| Gilead Sciences | Deborah H. Telman | EVP, Corporate Affairs & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 17,181 | 37,799 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Deborah H. Telman | EVP, Corporate Affairs & GC | Sale of securities on an exchange or to another person at price $ 124.00 per share. | 12 Nov 2025 | 17,181 | 43,676 (0%) | 0% | 124 | 2,130,444 | Common Stock |
| Boston Properties Inc | John J. Stroman | Executive Vice President | Sale of securities on an exchange or to another person at price $ 72.17 per share. | 12 Nov 2025 | 16,838 | 0 (0%) | 0% | 72.2 | 1,215,239 | Common Stock, par value $0.01 |
| General American Investors Co. Inc | Spencer Davidson | Chairman | Purchase of securities on an exchange or from another person at price $ 24.98 per share. | 12 Nov 2025 | 16,824 | 161,021 | - | 25.0 | 420,184 | 5.95% Preferred Stock |
| Cipher Mining Inc | Holly Morrow Evans | Director | Sale of securities on an exchange or to another person at price $ 17.39 per share. | 12 Nov 2025 | 16,269 | 210,512 | - | 17.4 | 282,918 | Common Stock |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 16,000 | 75,000 | - | - | Stock Option (right to buy) | |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.04 per share. | 12 Nov 2025 | 16,000 | 28,202 (0%) | 0% | 26.0 | 416,592 | Common Stock, par value $0.01 per share |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.40 per share. | 12 Nov 2025 | 16,000 | 44,202 (0%) | 0% | 8.4 | 134,400 | Common Stock, par value $0.01 per share |
| Cencora | Robert P. Mauch | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 15,960 | 15,960 | - | - | Restricted Stock Units | |
| Cannae Holdings Inc | William P. Foley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 15,635 | 1,008,235 (1%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | William H. Van Den Heuvel | Exec Vice President - Sub | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.70 per share. | 12 Nov 2025 | 15,471 | 43,422 (0%) | 0% | 70.7 | 1,093,800 | Common Stock |
| Cincinnati Financial | William H. Van Den Heuvel | Exec Vice President - Sub | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 15,471 | 0 | - | - | Stock Option (Right to Buy) | |
| Huntington Ingalls | Christopher D. Kastner | Director, Director, President & CEO | Sale of securities on an exchange or to another person at price $ 321.06 per share. | 12 Nov 2025 | 15,000 | 68,139 (0%) | 0% | 321.1 | 4,815,900 | Common Stock |
| TFS Fin Corp | Meredith S. Weil | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.85 per share. | 12 Nov 2025 | 15,000 | 48,527 (0%) | 0% | 13.9 | 207,750 | Common Stock |
| ACM Research Inc (Class A) | Lisa Feng | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 15,000 | 15,000 | - | - | Stock Option | |
| ACM Research Inc (Class A) | Lisa Feng | See remarks | Sale of securities on an exchange or to another person at price $ 33.77 per share. | 12 Nov 2025 | 15,000 | 50,001 (0%) | 0% | 33.8 | 506,550 | Class A Common Stock |
| ACM Research Inc (Class A) | Lisa Feng | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.60 per share. | 12 Nov 2025 | 15,000 | 65,001 (0%) | 0% | 5.6 | 84,000 | Class A Common Stock |
| ACM Research Inc (Class A) | Lisa Feng | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.60 per share. | 12 Nov 2025 | 15,000 | 65,001 (0%) | 0% | 5.6 | 84,000 | Class A Common Stock |
| ACM Research Inc (Class A) | Lisa Feng | See remarks | Sale of securities on an exchange or to another person at price $ 32.76 per share. | 12 Nov 2025 | 15,000 | 50,001 (0%) | 0% | 32.8 | 491,400 | Class A Common Stock |
| ACM Research Inc (Class A) | Lisa Feng | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 15,000 | 0 | - | - | Stock Option | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 12 Nov 2025 | 15,000 | 81,059 (0%) | 0% | 119.1 | 1,786,950 | Common Stock |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 15,000 | 10,000 | - | - | Performance Stock Option 2017 (right to buy) | |
| Collegium pharma Inc | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 15,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.49 per share. | 12 Nov 2025 | 15,000 | 79,634 (0%) | 0% | 16.5 | 247,350 | Common Stock |
| Procore Tech Inc | O Kevin J Connor | Director | Sale of securities on an exchange or to another person at price $ 78.58 per share. | 12 Nov 2025 | 14,776 | 1,072,263 | - | 78.6 | 1,161,098 | Common Stock |
| Akero Therapeutics Inc | Andrew Cheng | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 14,739 | 511,375 (1%) | 0% | 0 | Common Stock | |
| EZCorp Inc (Class A) | Sunil Sajnani | Chief Audit/LP Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 14,706 | 117,989 | - | - | Restricted Stock Units | |
| Danaher | Brian W. Ellis | Senior Vice President - GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 14,667 | 0 | - | - | Employee stock option (right to buy) | |
| Danaher | Brian W. Ellis | Senior Vice President - GC | Sale of securities on an exchange or to another person at price $ 219.23 per share. | 12 Nov 2025 | 14,667 | 14,553 (0%) | 0% | 219.2 | 3,215,477 | Common Stock |
| Danaher | Brian W. Ellis | Senior Vice President - GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.59 per share. | 12 Nov 2025 | 14,667 | 29,220 (0%) | 0% | 58.6 | 859,340 | Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 89.07 per share. | 12 Nov 2025 | 14,642 | 158,584 (1%) | 0% | 89.1 | 1,304,163 | Common Stock |
| Post Holdings Inc | Robert V. Vitale | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 14,582 | 29,165 | - | - | Restricted Stock Units | |
| Post Holdings Inc | Robert V. Vitale | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 14,582 | 942,258 (1%) | 0% | 0 | Common Stock | |
| WhiteHorse Finance Inc | Stuart D. Aronson | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.92 per share. | 12 Nov 2025 | 14,000 | 50,000 (0%) | 0% | 6.9 | 96,880 | Common Stock, par value $0.001 per share |
| EZCorp Inc (Class A) | Nicole Swies | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 13,918 | 132,699 | - | - | Restricted Stock Units | |
| Cencora | James F. Cleary | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.53 per share. | 12 Nov 2025 | 13,901 | 133,889 (0%) | 0% | 312.5 | 4,344,480 | Common Stock |
| Lincoln National Corp | John G. Morriss | EVP, Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 13,753 | 13,753 (0%) | 0% | 0 | Common Stock | |
| SEACOR Marine Holdings Inc | R. Christopher Regan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 13,515 | 48,485 (0%) | 0% | 0 | Common Stock | |
| InspireMD Inc | Paul S. Stuka | Director | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 12 Nov 2025 | 13,431 | 373,715 (10%) | 0% | 1.6 | 21,758 | Common Stock |
| Extreme Networks Inc | John C. Shoemaker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 0 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | John C. Shoemaker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 582,345 (0%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | Charles P. Carinalli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 0 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Charles P. Carinalli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 380,147 (0%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | Edward H. Kennedy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 626,045 (0%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | Edward H. Kennedy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 0 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Rajendra Khanna | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 230,062 (0%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | Rajendra Khanna | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 0 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Kathleen M. Holmgren | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 0 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Kathleen M. Holmgren | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 238,829 (0%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | Ingrid J. Burton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 93,517 (0%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | Ingrid J. Burton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 13,354 | 0 | - | - | Restricted Stock Units | |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 12,885 | 25,559 (0%) | 0% | 0 | Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 91.71 per share. | 12 Nov 2025 | 12,673 | 700 | - | 91.7 | 1,162,297 | Class A Common Stock |
| Agilent Tech | Padraig McDonnell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 12,490 | 0 | - | - | Employee Stock Option (Right-to-Buy) | |
| Agilent Tech | Padraig McDonnell | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 12 Nov 2025 | 12,490 | 33,448 (0%) | 0% | 150 | 1,873,500 | Common Stock |
| Agilent Tech | Padraig McDonnell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.86 per share. | 12 Nov 2025 | 12,490 | 45,938 (0%) | 0% | 109.9 | 1,372,151 | Common Stock |
| a.k.a. Brands Holding Corp | Ilene Eskenazi | Director | Sale of securities on an exchange or to another person at price $ 12.89 per share. | 12 Nov 2025 | 12,201 | 5,852 | - | 12.9 | 157,271 | Common Stock, $0.001 par value per share |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 12 Nov 2025 | 12,084 | 2,254,371 | - | 0.5 | 6,527 | Class A common stock, $0.0001 par value |
| Sanfilippo (John B.) & Son Inc | Jeffrey T. Sanfilippo | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,819 | 36,260 (0%) | 0% | 0 | Common Stock | |
| Sanfilippo (John B.) & Son Inc | Jasper B. Sanfilippo | Director, COO, President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,819 | 36,260 (0%) | 0% | 0 | Common Stock | |
| Extreme Networks Inc | John C. Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,767 | 11,767 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Charles P. Carinalli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,767 | 11,767 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Edward H. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,767 | 11,767 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Rajendra Khanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,767 | 11,767 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Kathleen M. Holmgren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,767 | 11,767 | - | - | Restricted Stock Units | |
| Extreme Networks Inc | Ingrid J. Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,767 | 11,767 | - | - | Restricted Stock Units | |
| Pluri Inc | Eitan Ajchenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 11,685 | 11,685 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp | Tony J. Hunt | Director | Sale of securities on an exchange or to another person at price $ 158.01 per share. | 12 Nov 2025 | 11,096 | 101,207 (0%) | 0% | 158.0 | 1,753,279 | Common Stock |
| Caterpillar | Denise C. Johnson | Group President | Other type of transaction at price $ 0.00 per share. | 12 Nov 2025 | 10,944 | 10,752 | - | - | Phantom Stock Units | |
| Zillow Grp Inc (Class A) | Jeremy Wacksman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.99 per share. | 12 Nov 2025 | 10,855 | 134,712 (0%) | 0% | 70.0 | 759,734 | Class C Capital Stock |
| Goldman Sachs BDC Inc | Tucker Greene | See Remarks | Purchase of securities on an exchange or from another person at price $ 9.86 per share. | 12 Nov 2025 | 10,500 | 10,500 (0%) | 0% | 9.9 | 103,533 | Common Stock, par value $0.001 per share |
| Cincinnati Financial | William H. Van Den Heuvel | Exec Vice President - Sub | Payment of exercise price or tax liability using portion of securities received from the company at price $ 166.85 per share. | 12 Nov 2025 | 10,377 | 33,045 (0%) | 0% | 166.8 | 1,731,402 | Common Stock |
| American Public Education Inc | Tanya J. Axenson | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 10,363 | 0 | - | - | Employee Stock Option (right to buy) | |
| American Public Education Inc | Tanya J. Axenson | SVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 34.77 per share. | 12 Nov 2025 | 10,363 | 58,403 (0%) | 0% | 34.8 | 360,305 | Common Stock, par value $.01 |
| American Public Education Inc | Tanya J. Axenson | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.74 per share. | 12 Nov 2025 | 10,363 | 68,766 (0%) | 0% | 15.7 | 163,114 | Common Stock, par value $.01 |
| AEye Inc (Class A) | Jonathon B. Husby | Director | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 12 Nov 2025 | 10,350 | 94,608 | - | 2.4 | 24,849 | Common Stock |
| Post Holdings Inc | Robert V. Vitale | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.02 per share. | 12 Nov 2025 | 10,232 | 927,676 (1%) | 0% | 106.0 | 1,084,797 | Common Stock |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.83 per share. | 12 Nov 2025 | 10,220 | 73,369 (0%) | 0% | 68.8 | 703,443 | Ordinary Shares |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 10,220 | 8,517 | - | - | NQ Options | |
| Plexus Corp | Todd P. Kelsey | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.24 per share. | 12 Nov 2025 | 10,145 | 70,152 (0%) | 0% | 146.2 | 1,483,605 | Common Stock, $.01 par value |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.40 per share. | 12 Nov 2025 | 10,000 | 38,202 (0%) | 0% | 8.4 | 84,000 | Common Stock, par value $0.01 per share |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 10,000 | 91,000 | - | - | Stock Option (right to buy) | |
| A-Mark Precious Metals Inc | Gregory N. Roberts | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.10 per share. | 12 Nov 2025 | 10,000 | 28,202 (0%) | 0% | 26.1 | 261,037 | Common Stock, par value $0.01 per share |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 10,000 | 0 | - | - | Performance Stock Option 2017 (right to buy) | |
| Alnylam Pharma Inc | Yvonne L Greenstreet | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.13 per share. | 12 Nov 2025 | 10,000 | 75,409 (0%) | 0% | 119.1 | 1,191,300 | Common Stock |
| Alarm.com Holdings Inc | Daniel Kerzner | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Alarm.com Holdings Inc | Daniel Kerzner | See Remarks | Sale of securities on an exchange or to another person at price $ 50.33 per share. | 12 Nov 2025 | 10,000 | 52,000 (0%) | 0% | 50.3 | 503,300 | Common Stock |
| Alarm.com Holdings Inc | Daniel Kerzner | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.02 per share. | 12 Nov 2025 | 10,000 | 62,000 (0%) | 0% | 15.0 | 150,200 | Common Stock |
| Amcor | Nicholas T. Long | Director | Purchase of securities on an exchange or from another person at price $ 8.54 per share. | 12 Nov 2025 | 10,000 | 62,911 (0%) | 0% | 8.5 | 85,374 | Ordinary Shares |
| Clearwater Analytics Holdings Inc (Class A) | Souvik Das | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.12 per share. | 12 Nov 2025 | 10,000 | 116,066 | - | 20.1 | 201,194 | Class A Common Stock |
| Clearwater Analytics Holdings Inc (Class A) | Souvik Das | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 12 Nov 2025 | 10,000 | 106,066 | - | 20.3 | 203,000 | Class A Common Stock |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 12 Nov 2025 | 10,000 | 2,244,371 | - | 0.6 | 5,606 | Class A common stock, $0.0001 par value |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 100.18 per share. | 12 Nov 2025 | 10,000 | 9,840,263 (34%) | 0% | 100.2 | 1,001,818 | Common Stock |
| First Horizon Corp | Jeff L. Fleming | EVP & Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 9,765 | 0 | - | - | Stock Options (Right to Buy) | |
| First Horizon Corp | Jeff L. Fleming | EVP & Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.43 per share. | 12 Nov 2025 | 9,765 | 136,245 (0%) | 0% | 15.4 | 150,674 | Common Stock |
| Donegal Grp Inc (Class A) | Daniel J. Wagner | Sr. VP & Treasurer | Sale of securities on an exchange or to another person at price $ 19.76 per share. | 12 Nov 2025 | 9,617 | 95,384 (0%) | 0% | 19.8 | 190,013 | Class A Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 9,610 | 168,042 (0%) | 0% | 0 | Common Stock | |
| Post Holdings Inc | Jeff A. Zadoks | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 9,538 | 0 | - | - | Restricted Stock Units | |
| Post Holdings Inc | Jeff A. Zadoks | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 9,538 | 55,843 (0%) | 0% | 0 | Common Stock | |
| Cencora | Elizabeth S. Campbell | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.53 per share. | 12 Nov 2025 | 9,532 | 26,388 (0%) | 0% | 312.5 | 2,979,036 | Common Stock |
| JPMC | Troy L. Rohrbaugh | Co-CEO CIB | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 9,500 | 141,626 (0%) | 0% | 0 | Common Stock | |
| Eagle Fin Services Inc | Scott M. Hamberger | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 9,467 | 874 | - | 0 | Common Stock, $2.50 Par Value | |
| Sweetgreen Inc (Class A) | Nicolas Jammet | Director, Chief Concept Officer | Purchase of securities on an exchange or from another person at price $ 5.45 per share. | 12 Nov 2025 | 9,140 | 9,140 | - | 5.5 | 49,813 | Class A Common Stock |
| Twin Disc Incorporated | John H. Batten | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 16.14 per share. | 12 Nov 2025 | 9,102 | 498,513 (3%) | 0% | 16.1 | 146,883 | COMMON STOCK |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 12 Nov 2025 | 9,086 | 625,165 (0%) | 0% | 16.6 | 150,918 | Common Stock |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 12 Nov 2025 | 9,085 | 660,675 (0%) | 0% | 16.6 | 150,902 | Common Stock |
| Collegium pharma Inc | Vikram Karnani | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.35 per share. | 12 Nov 2025 | 8,983 | 96,989 (0%) | 0% | 47.3 | 425,345 | Common Stock |
| Sweetgreen Inc (Class A) | Nicolas Jammet | Director, Chief Concept Officer | Purchase of securities on an exchange or from another person at price $ 5.57 per share. | 12 Nov 2025 | 8,975 | 18,115 | - | 5.6 | 49,991 | Class A Common Stock |
| Nature`s Sunshine Products Inc | Daniel C. Norman | EVP & President, Asia | Sale of securities on an exchange or to another person at price $ 20.46 per share. | 12 Nov 2025 | 8,884 | 66,636 (0%) | 0% | 20.5 | 181,767 | Common Shares |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 12 Nov 2025 | 8,808 | 634,251 (0%) | 0% | 16.6 | 146,301 | Common Stock |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 12 Nov 2025 | 8,808 | 651,867 (0%) | 0% | 16.6 | 146,301 | Common Stock |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 12 Nov 2025 | 8,808 | 643,059 (0%) | 0% | 16.6 | 146,301 | Common Stock |
| Procore Tech Inc | O Kevin J Connor | Director | Sale of securities on an exchange or to another person at price $ 76.30 per share. | 12 Nov 2025 | 8,576 | 1,063,173 | - | 76.3 | 654,349 | Common Stock |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 32.85 per share. | 12 Nov 2025 | 8,568 | 626,805 | - | 32.9 | 281,459 | Class A Ordinary Shares, par value $0.05 per share |
| TTM Tech Inc | Douglas L. Soder | EVP, Commercial Sector Pres. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 8,541 | 187,734 (0%) | 0% | 0 | Common Stock | |
| FiscalNote Holdings Inc (Class A) | Josh Resnik | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 12 Nov 2025 | 8,495 | 215,436 | - | 2.7 | 23,106 | Class A Common Stock |
| Donegal Grp Inc (Class A) | Daniel J. Wagner | Sr. VP & Treasurer | Sale of securities on an exchange or to another person at price $ 19.77 per share. | 12 Nov 2025 | 8,383 | 95,384 (0%) | 0% | 19.8 | 165,698 | Class A Common Stock |
| Post Holdings Inc | Diedre J. Gray | EVP, GC & CAO, SECY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 8,300 | 53,838 (0%) | 0% | 0 | Common Stock | |
| Post Holdings Inc | Diedre J. Gray | EVP, GC & CAO, SECY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 8,300 | 0 | - | - | Restricted Stock Units | |
| Innodata Inc | Louise C. Forlenza | Director | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 12 Nov 2025 | 8,278 | 3,943 (0%) | 0% | 65 | 538,070 | Common Stock |
| Roper Tech | L. Neil Hunn | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 452.40 per share. | 12 Nov 2025 | 8,000 | 95,311 (0%) | 0% | 452.4 | 3,619,160 | Common Stock |
| Zillow Grp Inc (Class A) | Jeremy Hofmann | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.53 per share. | 12 Nov 2025 | 7,865 | 70,811 (0%) | 0% | 69.5 | 546,853 | Class C Capital Stock |
| Cannae Holdings Inc | Barry B. Moullet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 32,753 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | Erika Meinhardt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 143,942 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | Frank P. Willey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 15,571 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | Frank R. Martire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 207,437 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | Hugh R. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 66,853 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | Mark Linehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 28,818 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | William Royan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 11,785 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | James B. Stallings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 34,279 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | C. Malcolm Holland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 34,733 (0%) | 0% | 0 | Common Stock | |
| Cannae Holdings Inc | Woodrow Tyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 7,818 | 12,887 (0%) | 0% | 0 | Common Stock | |
| GM | Christopher T. Hatto | Vice President & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 7,724 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| GM | Christopher T. Hatto | Vice President & CAO | Sale of securities on an exchange or to another person at price $ 72.00 per share. | 12 Nov 2025 | 7,724 | 12,007 (0%) | 0% | 72 | 556,128 | Common Stock |
| GM | Christopher T. Hatto | Vice President & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.16 per share. | 12 Nov 2025 | 7,724 | 19,731 (0%) | 0% | 52.2 | 402,884 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 90.73 per share. | 12 Nov 2025 | 7,710 | 13,373 | - | 90.7 | 699,491 | Class A Common Stock |
| First Horizon Corp | Jeff L. Fleming | EVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 21.74 per share. | 12 Nov 2025 | 7,619 | 128,626 (0%) | 0% | 21.7 | 165,660 | Common Stock |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 12 Nov 2025 | 7,509 | 617,656 (0%) | 0% | 16.6 | 124,724 | Common Stock |
| Astrazeneca PLC (ADR) | Aradhana Sarin | Executive Director,Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 177.27 per share. | 12 Nov 2025 | 7,500 | 102,250 (0%) | 0% | 177.3 | 1,329,518 | Ords 0.25p |
| Perrigo Co PLC | Geoffrey M. Parker | Director | Purchase of securities on an exchange or from another person at price $ 14.18 per share. | 12 Nov 2025 | 7,500 | 17,375 (0%) | 0% | 14.2 | 106,350 | Ordinary Shares |
| PTC Therapeutics Inc | Emma Reeve | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 7,333 | 1,467 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Emma Reeve | Director | Sale of securities on an exchange or to another person at price $ 74.50 per share. | 12 Nov 2025 | 7,333 | 6,666 (0%) | 0% | 74.5 | 546,309 | Common Stock |
| PTC Therapeutics Inc | Emma Reeve | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.54 per share. | 12 Nov 2025 | 7,333 | 13,999 (0%) | 0% | 46.5 | 341,278 | Common Stock |
| FRP Holdings Inc | John D. Baker | Director | Purchase of securities on an exchange or from another person at price $ 23.85 per share. | 12 Nov 2025 | 7,175 | 199,025 (2%) | 0% | 23.9 | 171,124 | Common Stock |
| Sezzle Inc | Paul Paradis | Director, Director & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.01 per share. | 12 Nov 2025 | 7,110 | 514,162 | - | 58.0 | 412,451 | Common Stock, par value $0.00001 per share |
| Danaher | Brian W. Ellis | Senior Vice President - GC | Sale of securities on an exchange or to another person at price $ 219.21 per share. | 12 Nov 2025 | 7,109 | 14,553 (0%) | 0% | 219.2 | 1,558,386 | Common Stock |
| Danaher | Brian W. Ellis | Senior Vice President - GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.59 per share. | 12 Nov 2025 | 7,109 | 21,662 (0%) | 0% | 58.6 | 416,516 | Common Stock |
| Danaher | Brian W. Ellis | Senior Vice President - GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 7,109 | 0 | - | - | Employee stock option (right to buy) | |
| Watts Water Tech Inc (Class A) | Timothy P. Horne | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 278.65 per share. | 12 Nov 2025 | 6,994 | 23,006 (0%) | 0% | 278.6 | 1,948,878 | Class A Common Stock |
| Bridgewater Bancshares Inc | Jerry J. Baack | Director, CEO | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 12 Nov 2025 | 6,993 | 1,164,361 (4%) | 0% | 17.0 | 118,887 | Common Stock |
| Sezzle Inc | Charlie Youakim | Director, Executive Chairman and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.01 per share. | 12 Nov 2025 | 6,985 | 12,339,464 | - | 58.0 | 405,200 | Common Stock, par value $0.00001 per share |
| Sezzle Inc | Amin Sabzivand | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.01 per share. | 12 Nov 2025 | 6,976 | 228,583 | - | 58.0 | 404,678 | Common Stock, par value $0.00001 per share |
| Amgen | Murdo Gordon | EVP, Global Commercial Ops | Sale of securities on an exchange or to another person at price $ 336.83 per share. | 12 Nov 2025 | 6,879 | 41,923 (0%) | 0% | 336.8 | 2,317,071 | Common Stock |
| Seagate Tech | Gianluca Romano | EVP & CFO | Sale of securities on an exchange or to another person at price $ 283.46 per share. | 12 Nov 2025 | 6,836 | 85,532 (0%) | 0% | 283.5 | 1,937,722 | Ordinary Shares |
| Morningstar Inc | Joseph D. Mansueto | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 215.28 per share. | 12 Nov 2025 | 6,708 | 8,639,596 (20%) | 0% | 215.3 | 1,444,067 | Common Stock |
| Insmed Inc | S. Nicole Schaeffer | Chief People Strategy Officer | Sale of securities on an exchange or to another person at price $ 193.64 per share. | 12 Nov 2025 | 6,575 | 55,808 (0%) | 0% | 193.6 | 1,273,183 | Common Stock |
| Monolithic Power | Michael R. Hsing | Director, CEO | Sale of securities on an exchange or to another person at price $ 966.45 per share. | 12 Nov 2025 | 6,562 | 927,906 (2%) | 0% | 966.5 | 6,341,845 | Common Stock |
| Sanfilippo (John B.) & Son Inc | Frank S. Pellegrino | CFO & EVP, Finance and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 6,500 | 35,298 (0%) | 0% | 0 | Common Stock | |
| Post Holdings Inc | Robert V. Vitale | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.02 per share. | 12 Nov 2025 | 6,424 | 935,834 (1%) | 0% | 106.0 | 681,072 | Common Stock |
| Bellring Brands Inc | Paul A. Rode | CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 27.61 per share. | 12 Nov 2025 | 6,410 | 79,100 (0%) | 0% | 27.6 | 176,980 | Common Stock |
| Oncology Institute Inc | Daniel Virnich | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 6,211 | 1,793,520 | - | 0 | Common Stock | |
| Post Holdings Inc | Matthew J. Mainer | EVP, CFO & TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 6,008 | 52,720 (0%) | 0% | 0 | Common Stock | |
| Post Holdings Inc | Matthew J. Mainer | EVP, CFO & TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 6,008 | 0 | - | - | Restricted Stock Units | |
| Donegal Grp Inc (Class A) | Daniel J. Wagner | Sr. VP & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 6,000 | 0 | - | - | Options | |
| Donegal Grp Inc (Class A) | Daniel J. Wagner | Sr. VP & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.76 per share. | 12 Nov 2025 | 6,000 | 105,001 (0%) | 0% | 15.8 | 94,560 | Class A Common Stock |
| Donegal Grp Inc (Class A) | Daniel J. Wagner | Sr. VP & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.09 per share. | 12 Nov 2025 | 6,000 | 101,384 (0%) | 0% | 14.1 | 84,540 | Class A Common Stock |
| Donegal Grp Inc (Class A) | Daniel J. Wagner | Sr. VP & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 6,000 | 12,000 | - | - | Options | |
| Medalist Diversified REIT Inc | Frank Kavanaugh | Director, CHAIRMAN, CEO & PRESIDENT, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.28 per share. | 12 Nov 2025 | 5,953 | 203,979 (4%) | 0% | 13.3 | 79,056 | Common Stock |
| Plexus Corp | Todd P. Kelsey | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 5,943 | 34,733 | - | - | Performance Stock Units | |
| Zillow Grp Inc (Class A) | Errol G. Samuelson | Chief Industry Dev. Officer | Sale of securities on an exchange or to another person at price $ 70.81 per share. | 12 Nov 2025 | 5,816 | 122,640 (0%) | 0% | 70.8 | 411,824 | Class C Capital Stock |
| Zillow Grp Inc (Class A) | Jeremy Wacksman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 70.81 per share. | 12 Nov 2025 | 5,750 | 147,363 (0%) | 0% | 70.8 | 407,169 | Class C Capital Stock |
| Vicor Corp | Patrizio Vinciarelli | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 101.10 per share. | 12 Nov 2025 | 5,724 | 9,834,539 (34%) | 0% | 101.1 | 578,711 | Common Stock |
| Seagate Tech | Gianluca Romano | EVP & CFO | Sale of securities on an exchange or to another person at price $ 281.49 per share. | 12 Nov 2025 | 5,712 | 96,768 (0%) | 0% | 281.5 | 1,607,867 | Ordinary Shares |
| LyondellBasell (Class A) | Kimberly A. Foley | EVP, Global O&P and Refining | Purchase of securities on an exchange or from another person at price $ 43.56 per share. | 12 Nov 2025 | 5,661 | 67,687 (0%) | 0% | 43.6 | 246,621 | Class A Ordinary Shares |
| Cleveland-Cliffs Inc | Edilson Camara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 5,633 | 22,283 (0%) | 0% | 0 | Common Shares | |
| Monolithic Power | Michael R. Hsing | Director, CEO | Sale of securities on an exchange or to another person at price $ 965.50 per share. | 12 Nov 2025 | 5,619 | 934,468 (2%) | 0% | 965.5 | 5,425,145 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.53 per share. | 12 Nov 2025 | 5,612 | 19,947 (0%) | 0% | 312.5 | 1,753,918 | Common Stock |
| Adtalem Global Education Inc | Michael Betz | Pres. Walden University & CDO | Grant, award, or other acquisition of securities at price $ 96.86 per share. | 12 Nov 2025 | 5,575 | 33,727 (0%) | 0% | 96.9 | 539,995 | Common Stock |
| CervoMed Inc | John J. Alam | Director, CEO & President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.35 per share. | 12 Nov 2025 | 5,553 | 1,467,131 (4%) | 0% | 7.4 | 40,815 | Common Stock |
| CervoMed Inc | Sylvie Gregoire | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.35 per share. | 12 Nov 2025 | 5,553 | 1,467,131 (4%) | 0% | 7.4 | 40,815 | Common Stock |
| EZCorp Inc (Class A) | Michael Croney | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 5,515 | 12,540 | - | - | Restricted Stock Units | |
| American Public Education Inc | Nuno S. Fernandes | President, APUS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.66 per share. | 12 Nov 2025 | 5,500 | 87,749 (0%) | 0% | 10.7 | 58,630 | Common Stock, par value $.01 |
| American Public Education Inc | Nuno S. Fernandes | President, APUS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 5,500 | 17,056 | - | - | Employee Stock Option (right to buy) | |
| American Public Education Inc | Nuno S. Fernandes | President, APUS | Sale of securities on an exchange or to another person at price $ 34.68 per share. | 12 Nov 2025 | 5,500 | 82,249 (0%) | 0% | 34.7 | 190,740 | Common Stock, par value $.01 |
| Uber | Prashanth Mahendra-Rajah | CFO | Sale of securities on an exchange or to another person at price $ 94.41 per share. | 12 Nov 2025 | 5,500 | 20,330 (0%) | 0% | 94.4 | 519,234 | Common Stock |
| JFrog Ltd | Yvonne L. Wassenaar | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 5,487 | 23,820 | - | 0 | Ordinary Shares | |
| Comerica Inc | Christine M. Moore | EVP and Chief Audit Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.43 per share. | 12 Nov 2025 | 5,464 | 31,447 (0%) | 0% | 79.4 | 434,006 | Common Stock |
| Zillow Grp Inc (Class A) | Dan Spaulding | Chief People Officer | Sale of securities on an exchange or to another person at price $ 69.40 per share. | 12 Nov 2025 | 5,455 | 50,342 (0%) | 0% | 69.4 | 378,553 | Class C Capital Stock |
| BGC Grp Inc (Class A) | David Pender Richards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 5,447 | 24,999 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| BGC Grp Inc (Class A) | Linda A. Bell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 5,447 | 41,044 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| BGC Grp Inc (Class A) | Arthur U. Mbanefo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 5,447 | 24,756 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| GigaCloud Tech Inc (Class A) | Xinyan Hao | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 32.36 per share. | 12 Nov 2025 | 5,446 | 656,805 | - | 32.4 | 176,233 | Class A Ordinary Shares, par value $0.05 per share |
| California Resources Corp - Ordinary Shares - New | Francisco J. Leon | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 47.71 per share. | 12 Nov 2025 | 5,425 | 304,834 (0%) | 0% | 47.7 | 258,816 | Common Stock |
| Post Holdings Inc | Diedre J. Gray | EVP, GC & CAO, SECY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 5,422 | 10,846 | - | - | Restricted Stock Units | |
| Post Holdings Inc | Diedre J. Gray | EVP, GC & CAO, SECY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 5,422 | 55,603 (0%) | 0% | 0 | Common Stock | |
| Seagate Tech | Gianluca Romano | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.34 per share. | 12 Nov 2025 | 5,364 | 63,149 (0%) | 0% | 87.3 | 468,492 | Ordinary Shares |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.